SA-16

N/A

Report date: 2026/01/20 18:01:38
NME

Base Information

Drug NameSA-16
Drug Alias NameSA-16
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3-phosphoinositide-dependent protein kinase 1 inhibitors
Targets3-phosphoinositide-dependent protein kinase 1
Therapy Area/IndicationsSarcoma, Ewing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pisa
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Pisa
Inactive CompaniesN/A
Active IndicationsSarcoma, Ewing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A